Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M
Fierce Pharma
Thu, 04/11/24 - 11:31 am
Tags:
Pfizer, legal, Wyeth, M&A, pay-for-delay, antitrust
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
Tags:
oncology, clinical trials, Bristol Myers Squibb, Opdivo, Yervoy, liver cancer, Pfizer, DLBCL, Adcetris, Asieris, HSIL, APL-1702, cervical cancer, Novocure, non-small cell lung cancer, Roche, Genentech, Tecentriq, esophageal squamous cell carcinoma
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data
BioSpace
Tue, 04/9/24 - 11:18 am
Tags:
Pfizer, RSV, Abrysvo, clinical trials, vaccines
Roivant reveals positive immune drug data, share buyback plans
BioPharma Dive
Tue, 04/2/24 - 10:01 pm
Tags:
Roivant, clinical trials, uveitis, Pfizer, brepocitinib, non-infectious uveitis
Pfizer moves creative from IPG to Publicis after just 10 months
Medical Marketing and Media
Thu, 03/28/24 - 11:09 am
Tags:
Pfizer, Publicis, IPG, pharma marketing
Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment
BioSpace
Wed, 03/27/24 - 10:58 am
Tags:
Pfizer, sickle cell disease, inclacumab, clinical trials
Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
Tags:
China, Pharma CEOs, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Novartis, Pfizer, Takeda
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma
Clinical Trials Arena
Thu, 03/21/24 - 06:41 pm
Tags:
bladder cancer, urothelial cancer, Merck, Pfizer, Bristol Myers Squibb, Padcev, Keytruda, Balversa, Opdivo
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Tags:
Pfizer, Braftovi, Roche, Zelboraf, melanoma
J&J alleges ex-staffer downloaded thousands of files in move to Pfizer
Seeking Alpha
Wed, 03/20/24 - 11:48 am
Tags:
JNJ, Pfizer, legal, trade secrets
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
Tags:
M&A, Bristol Myers Squibb, Novartis, AstraZeneca, Novo Nordisk, Pfizer
Pfizer to cut stake in Haleon to 24%
Reuters
Mon, 03/18/24 - 11:04 am
Tags:
Pfizer, Haleon, consumer health
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
Fri, 03/15/24 - 11:13 am
Tags:
Pfizer, obesity, M&A, Viking Therapeutics
With Pfizer struggling in 2023, CEO Bourla hit with 35% pay cut to $21.6M
Fierce Pharma
Fri, 03/15/24 - 10:54 am
Tags:
Pfizer, Pharma CEOs, executive compensation, Albert Bourla
Pfizer-backed Mission raises £25.2m to progress clinical development of key drugs
Business Weekly
Thu, 03/14/24 - 11:28 am
Tags:
Mission Therapeutics, Pfizer, funding, MTX325, MTX652
Pfizer's blood cancer therapy Adcetris succeeds in late-stage trial
Reuters
Tue, 03/12/24 - 11:08 am
Tags:
Pfizer, Adcetris, lymphoma, clinical trials, Seagen
COVID vaccine giants Moderna and Pfizer employ divergent tactics for the next chapter
Pharma Voice
Mon, 03/11/24 - 11:43 am
Tags:
Moderna Therapeutics, Pfizer, vaccines, COVID-19, M&A, cancer
IRA Drives Pfizer’s Decision to Focus on Biologics, Not Small Molecules
BioSpace
Wed, 03/6/24 - 11:17 am
Tags:
Pfizer, oncology, Inflation Reduction Act, biologics
Bayer pays $310M to buy into BridgeBio heart drug
BioPharma Dive
Mon, 03/4/24 - 11:52 am
Tags:
BridgeBio, Bayer, acoramidis, Pfizer, Vyndamax, transthyretin amyloidosis cardiomyopathy
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
Tags:
oncology, cancer, antibody-drug conjugate, Merck, AbbVie, Pfizer, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.